|Publication number||US7836920 B2|
|Application number||US 12/576,674|
|Publication date||23 Nov 2010|
|Filing date||9 Oct 2009|
|Priority date||16 Sep 2004|
|Also published as||CA2578440A1, CA2578440C, CN100562459C, CN101018710A, EP1789323A2, EP1789323A4, US7204277, US7415994, US7490636, US7726361, US20060054241, US20070151618, US20070151626, US20080283146, US20100032052, WO2006036204A2, WO2006036204A3|
|Publication number||12576674, 576674, US 7836920 B2, US 7836920B2, US-B2-7836920, US7836920 B2, US7836920B2|
|Original Assignee||B. Braun Medical, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (64), Non-Patent Citations (10), Classifications (12), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This is a continuation application filed in accordance with 35 U.S.C. §120 that claims priority to U.S. patent application Ser. No. 12/180,932, filed Jul. 28, 2008, which claims priority to U.S. patent application Ser. No. 11/713,267, filed Mar. 2, 2007, now U.S. Pat. No. 7,415,994, which claims priority to U.S. application Ser. No. 10/942,529, filed Sep. 16, 2004, now U.S. Pat. No. 7,204,277. The contents of all the foregoing priority U.S. Patent Applications and U.S. Patents are incorporated by reference herein in their entireties and for all purposes.
The present invention relates generally to compounder systems, and more particularly, to a compounder system having a bypass for transferring different types of solutions into separated chambers of a receiving receptacle.
Hyperalimentation therapy is the intravenous feeding of nutrients to patients. A typical solution would include a protein-carbohydrate mixture. It is used primarily to meet the patient's protein and caloric requirements that are unable to be satisfied by oral feeding. The protein may be in the form of free-amino acids or protein hydrolysate and the carbohydrate commonly is dextrose. In addition to the protein and carbohydrate, vitamins (water-soluble and fat-soluble) and electrolytes also can be supplied in this therapy.
Each of these parenteral ingredients and the combination thereof are particularly susceptible to the growth of deleterious organisms and it is desirable that they be administered to the patient in a sterile condition. In addition, the solutions are tailor made to specific patient requirements under the direction of a physician. Thus, because these protein and carbohydrate solutions must be combined close, but prior, to their time of use, their compounding must be performed under sterile conditions to avoid organism growth.
As a part of this compounding, the solutions that are to be administered intravenously are transferred into a total parental nutrition bag (commonly referred to as a TPN bag). Such bags are designed for home use or use in a hospital or care facility. Once filled they can be stored for a limited period of time in a standard refrigerator. The bags are filled with the solutions by a pharmacist either by gravity or by a device known as a high speed bulk compounder. Such compounders typically are capable of supplying solutions from up to nine different source bags (and possibly more) or containers to a receiving product bag at relatively high flow rates.
The source containers may be hung from a framework of the compounder while the receiving bag is hung from a load cell that measures the weight of the receiving bag. A pump set consisting of a number of pump legs (for example, nine or more such legs) or flow paths is designed to be used with the compounder. Each of the pump legs includes flexible tubing and terminates on one end with a piercing administration spike or similar connector that is used to connect the leg of the pump set to one of the source containers. The other end of each leg is coupled to one of the inlet ports of a common manifold equipped with an exit port that is adapted to be coupled to a fill tubing connected to the receiving TPN product bag.
In those instances where a high-speed compounder is used, each leg of the pump set is associated with a different peristaltic pump or pump station of the compounder. A microprocessor in the compounder controls each of the peristaltic pumps or pump stations to thereby control the amount of solution being supplied from each source container through the particular pump leg and the manifold to the receiving product bag. The amount of solution being supplied from each source container is in part determined by information being supplied to the microprocessor of the weight being measured at selected times by the load cell from which the receiving bag is suspended. The peristaltic pumps draw solutions from each of the source containers sequentially under the control of the microprocessor and the solutions flow through the common manifold and the fill tubing into the receiving product bag.
A problem arises when one of the fluids to be introduced into the product bag is a lipid solution. Lipid solutions are essentially fat emulsions and typically are placed into a separate compartment within the product bag which is isolated from the remaining mixture until immediately before (or very soon before) the solution is administered to a patient. This isolation is necessary because the lipid solution, if mixed with the other ingredients ahead of time, clouds the overall solution mixture and renders it unusable. This phenomena is known in the art as “hazing.” Because of the undesirability of mixing lipids with the other solutions prior to the time of administration, a problem has existed in the prior art where a residual amount of the lipid solution is allowed to remain in a common volume of the manifold after a lipid solution is pumped through but before the next non-lipid solution is pumped through. When the subsequent solution is pumped through, the residual lipid solution is carried into the product bag and hazing results.
One solution has involved the use of a chambered product bag. By pumping the lipids into a separate chamber of the product bag, the lipids will not mix and “haze” the solution. Immediately before the solution is used, the separated chamber with the lipids is allowed to mix with the remaining solution to form the product solution. To fill the chambered bag using conventional compounders, one line of the compounder must be devoted specifically for lipids and be attached directly to the separated chamber of the product bag. By using the compounder in this manner, however, one line is not used if the overall solution does not require a lipid component.
The present invention is directed to a tube set for dispensing components into a product bag. The tube set comprises a plurality of tubing lines, a manifold, and a bypass. The manifold has a plurality of inlets, each inlet adapted for connection to a respective tubing line. The manifold also has an outlet connectable to a first feed tube of a product bag. The bypass is associated with at least one of the plurality of tubing lines. The bypass has a bypass inlet connectable to the tubing line associated with the bypass. The bypass also has at least two outlets. A first outlet is connected to a tube line in fluid communication with an inlet of the manifold and a second outlet is removably connectable to a second feed line in fluid communication with the product bag.
According to another embodiment, the present invention is directed to a bypass for a tube set. The tube set includes a manifold and a plurality of tubing lines for dispensing fluid components into a product bag. The bypass comprises an inlet fluid passage adapted for connection to a tubing line of the tube set, an outlet adapted to receive a tubing line in fluid communication with the product bag, and a bypass fluid passage adapted for connection to a tubing line in fluid communication with the manifold. The bypass is configured such that fluid enters the bypass inlet fluid passage and exits through the outlet only when the outlet is connected to a tubing line in direct fluid communication with the product bag.
An exemplary method of the present invention is a method for selectively dispensing fluid components into a product bag attached to a tube set of a bulk compounder. The bulk compounder includes a product bag attached to a tube set having a plurality of tube lines, a manifold, and a bypass having a fluid passage with an inlet and at least two outlets. The method includes providing liquid components to be dispensed into the product bag with one of the liquid components to be maintained separately from the other liquid components, inserting a tube line in fluid communication with the product bag into the bypass first outlet, blocking the bypass second outlet in fluid communication to the manifold, and dispensing the fluid component to be maintained separate from the other liquid components through the bypass and into the product bag, independent of the manifold.
Although the invention is illustrated and described herein with reference to specific embodiments, the invention is not intended to be limited to the details shown. Rather, various modifications may be made in the details within the scope and range of equivalents of the claims and without departing from the invention.
Referring to the Figures where like numerals represent like features,
As one example, due to injury, disease, or trauma, a patient may need to receive all or some of his or her nutritional requirements intravenously. In this situation, the patient will typically receive a basic solution containing a mixture of amino acids, dextrose, and fat emulsions, which provide a major portion of the patient's nutritional needs, which is called total parenteral nutrition, or, in shorthand, TPN. In this arrangement, a physician will prescribe a mixture of amino acids, dextrose, and fat emulsions to be administered, as well as the frequency of administration. To maintain a patient for an extended period of time on TPN, smaller volumes of additional additives, such as vitamins, minerals, electrolytes, etc., are also prescribed for inclusion in the mix. Using system 10, under the supervision of a pharmacist, the prescription order is entered and individual doses of the prescribed liquids, drugs, and/or additives are accordingly transferred from separate individual source containers for mixing in a single container for administration to the individual.
There are other environments where system 10 is well suited for use. For example, in the medical field, system 10 can be used to compound liquids and/or drugs in support of chemotherapy, cardioplegia, therapies involving the administration of antibiotics and/or blood products therapies, and in biotechnology processing, including diagnostic solution preparation and solution preparation for cellular and molecular process development. Furthermore, system 10 can be used to compound liquids outside the medical field.
Tube set 15 is a part of system 10. Tube set 15 includes lengths of transfer tubing line 20, which are joined at one end to a common manifold 45. At the opposite ends of the transfer tubing 15 are spikes or releasable couplings 100. Couplings 100 can be inserted in conventional fashion through a diaphragm carried by the associated source solution container (not shown), which allows flow communication between the source solution container and the respective transfer tubing line 20. From manifold 45, a first feed line 50 is coupled to a product bag 80. As shown in the embodiment of
Also shown in
As shown in the embodiment of
Referring again to
When a lipid solution is not used in the formulation, i.e., when components of the liquid need not remain separate from the other components, second feed line 60 may be removed from bypass 23. Thus, the liquid in the tube line connected to bypass inlet 25 will flow to bypass 23 and will exit via bypass fluid passage 200, which is connected via tubing 40 to manifold 45. The fluid flow direction is shown by line B in
According to an embodiment of the present invention, tube set 15 connected to manifold 45 and bypass 23 can be fabricated independently and joined together to form a single device made up of these individual components. Preferably, these components can be ultrasonically welded to their respective mate. The means of joining the components are discussed in detail below. The primary advantage to such a construction is ease of manufacture.
Bypass 23 could be made from any of a number of suitable materials, including plastics, such as polycarbonates, that are suitable to handle the pharmaceutical and food preparations that will be passing therethrough. The suitable materials should also preferably be such that they can be injection molded to form the parts of the device, or the whole device, and one skilled in the art would know such materials.
While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3941126||8 Aug 1974||2 Mar 1976||Dietrich Joseph W||Apparatus for long term intravenous administration of diluted incompatible multiple medications|
|US4467844||24 Jun 1982||28 Aug 1984||Baxter Travenol Laboratories, Inc.||Flow monitoring method and apparatus|
|US4513796||24 Jun 1982||30 Apr 1985||Baxter Travenol Laboratories, Inc.||High speed bulk compounder|
|US4648430||14 Apr 1986||10 Mar 1987||Baxter Travenol Laboratories, Inc.||Device and method for collecting a desired weight amount of a material|
|US4653010||26 Oct 1984||24 Mar 1987||Baxter Travenol Laboratories, Inc.||Compounding system|
|US4712590||30 May 1986||15 Dec 1987||Baxter Travenol Laboratories, Inc.||Electrical connection means for multiple bulk compounding systems|
|US4718467||30 May 1986||12 Jan 1988||Baxter Travenol Laboratories, Inc.||Pumping module arrangement and manifold|
|US4789014||12 Jan 1988||6 Dec 1988||Baxter International Inc.||Automated system for adding multiple fluids to a single container|
|US4823833||11 Sep 1984||25 Apr 1989||Baxter Healthcare Corporation||Fluid communication device|
|US4922975||16 Jan 1987||8 May 1990||Fresenius Ag||Apparatus for making mixtures of pharmaceutical liquids|
|US4967811||17 Oct 1988||6 Nov 1990||Clintec Nutrition Company||Automated system for adding multiple fluids to a single container|
|US5025954||1 Feb 1990||25 Jun 1991||Hamburger Color Company||Multi-components measuring and dispensing system|
|US5040699||15 May 1989||20 Aug 1991||Gangemi Ronald J||Fluid compounding method and apparatus|
|US5056568||4 May 1990||15 Oct 1991||Clintec Nutrition Company||Automated system for adding multiple fluids to a single container|
|US5076332||16 Apr 1990||31 Dec 1991||Clintec Nitrition Co.||Arch geometry to eliminate tubing influence on load cell accuracy|
|US5085256||29 Mar 1990||4 Feb 1992||Clintec Nutrition Co.||Drift stabilization check|
|US5128048||22 May 1991||7 Jul 1992||Baxter International Inc.||Systems and methods for removing undesired matter from blood cells|
|US5180504||22 May 1991||19 Jan 1993||Baxter International Inc.||Systems and methods for removing undesired matter from blood cells|
|US5193594 *||6 Apr 1992||16 Mar 1993||Norapp-Jon H. Andresen||Arrangement for injecting additives|
|US5313992||11 Dec 1992||24 May 1994||Abbott Laboratories||Transfer tubing set for compounding solutions|
|US5316181||12 Apr 1993||31 May 1994||Integrated Designs, Inc.||Liquid dispensing system|
|US5355915 *||16 Sep 1992||18 Oct 1994||Gilbarco||Vapor recovery improvements|
|US5364526||17 Aug 1993||15 Nov 1994||Pall Corporation||System for processing separate containers of biological fluid|
|US5402834||25 Nov 1992||4 Apr 1995||Merck & Co., Inc.||Solution preparation system|
|US5431185||15 Jul 1994||11 Jul 1995||Pacific Device Inc.||Manifold for infusing medical fluids|
|US5431201||3 Dec 1993||11 Jul 1995||Technology 2000 Incororated||Robotic admixture system|
|US5431202||17 Sep 1993||11 Jul 1995||W. Cary Dikeman||Medical fluid flow control system and compounder apparatus|
|US5450847||24 Oct 1991||19 Sep 1995||Schering Aktiengesellschaft||Process for making doses formulation of contrast media from concentrate|
|US5464047||24 Jan 1994||7 Nov 1995||Benjamin Moore & Co.||Method and apparatus for dispensing paint into containers|
|US5470488||14 Jul 1994||28 Nov 1995||Pall Corporation||Method for processing separate containers of biological fluid|
|US5507412||14 Jun 1994||16 Apr 1996||Dragerwerk Ag||Centralized multichannel fluid delivery system|
|US5510621||3 Oct 1994||23 Apr 1996||Optical Solutions, Inc.||Apparatus and method for measuring components in a bag|
|US5511594||23 Jun 1992||30 Apr 1996||Brennan; Eric L.||Modular pharmacy system and pharmacy process|
|US5592940||19 Sep 1995||14 Jan 1997||Schering Aktiengesellschaft||Process for making doses formulation of contrast media from concentrate|
|US5597094||12 Jul 1995||28 Jan 1997||Solignac Industries S.A.||Device with peristaltic pump which makes it possible to draw, weight and mix liquids automatically|
|US5601730||1 Sep 1993||11 Feb 1997||Pall Corporation||Process and apparatus for removal of unwanted fluids from processed blood products|
|US5626172||23 Dec 1993||6 May 1997||Clintec Nutrition Company||Transfer set|
|US5637103||17 Mar 1993||10 Jun 1997||Kerwin; Michael J.||Fluid collection and disposal system|
|US5697407||30 Nov 1995||16 Dec 1997||The Metrix Company||Compounding system for multiple chamber receptacles|
|US5750998||16 Feb 1996||12 May 1998||Baxter International, Inc.||Apparatus and method for non invasively identifying components of liquid medium within a bag|
|US5772966||24 Jan 1997||30 Jun 1998||Maracas; George N.||Assay dispensing apparatus|
|US5820048||9 Apr 1996||13 Oct 1998||Illinois Tool Works Inc.||Side latching hinge mechanism|
|US5927349||9 Dec 1996||27 Jul 1999||Baxter International Inc.||Compounding assembly for nutritional fluids|
|US5989423||10 Sep 1996||23 Nov 1999||Deka Products Limited Partnership||Disposable cassette, delivery set and system for peritoneal dialysis|
|US6079462||24 Feb 1999||27 Jun 2000||Baxter International Inc.||Compounding assembly for nutritional fluids|
|US6171287 *||28 May 1999||9 Jan 2001||Lawrence A. Lynn||Luer receiver and method for fluid transfer|
|US6199603||11 Aug 1999||13 Mar 2001||Baxter International Inc.||Compounding assembly for nutritional fluids|
|US6202711||17 Apr 2000||20 Mar 2001||Baxter International Inc.||Compounding assembly for nutritional fluids|
|US6213174||12 Feb 1999||10 Apr 2001||Blue Boy International Limited||Portioning of flowable products|
|US6296450||3 Sep 1999||2 Oct 2001||Baxter International Inc.||Systems and methods for control of pumps employing gravimetric sensing|
|US6319243||29 Jan 1998||20 Nov 2001||Baxter International, Inc.||Containers and methods for storing and admixing medical solutions|
|US6422465 *||1 Dec 2000||23 Jul 2002||Marathon Ashland Petroleum Llc||Bar code gasoline blending|
|US6488860||24 Mar 1998||3 Dec 2002||Fresenius Ag||Device and method for separating blood into blood components|
|US6669681||11 Jul 2001||30 Dec 2003||Baxter International Inc.||Needleless connector|
|US6951228||4 Dec 2003||4 Oct 2005||B Braun Medical Inc.||Bulk compounder manifold|
|US7252122 *||22 Nov 2005||7 Aug 2007||B. Braun Medical Inc.||Bulk compounder manifold|
|US20020035412||4 Dec 2000||21 Mar 2002||Kircher Joseph J.||Method and apparatus for controlling the strategy of compounding pharmaceutical admixtures|
|JPH03237983A||Title not available|
|JPH07506518A||Title not available|
|WO2000009069A1||12 Aug 1999||24 Feb 2000||Baxter Int||Compounding assembly for nutritional fluids|
|WO2003058507A1||31 Dec 2002||17 Jul 2003||Braun Medical Inc||Pharmaceutical compounding information management system|
|WO2005030286A1||24 Sep 2004||7 Apr 2005||Scimed Life Systems Inc||Medical device with markers for magnetic resonance visibility|
|WO2005061328A1||5 Oct 2004||7 Jul 2005||Braun Medical Inc||Bulk compounder manifold|
|WO2006036204A2||11 Apr 2005||6 Apr 2006||Braun Medical Inc||By-pass line connector for compounding system|
|1||European Patent Office Action for Application No. EP 05 73 533.2-2310, dated Jan. 20, 2009.|
|2||First Office Action Dated Jan. 23, 2009, State Intellectual Property Office in China for Chinese Patent Application No. CN 2005800310929 (with English Translation).|
|3||First Office Action Dated Sep. 17, 2008, State Intellectual Property Office in China for Chinese Patent Application No. CN 2005800310929 (with English Translation).|
|4||International Preliminary Report on Patentability for International Application No. PCT/US2005/012169, Report Issued, Mar. 20, 2007.|
|5||International Search Report for PCT/US05/12169 Published Nov. 6, 2006.|
|6||Japanese Office Action dated Aug. 10, 2010 for JP Patent Application No. 2007-532310 with an English language translation.|
|7||Non-Final Office Action for U.S. Appl. No. 11/713,267, Dated Feb. 14, 2008.|
|8||Non-Final Office Action of U.S. Appl. No. 12/180,932, dated Oct. 21, 2009.|
|9||Supplemental European Search Report for EP 05 73 5330, Dated Oct. 24, 2008.|
|10||Written Opinion of the International Searching Authority for International Application No. PCT/US05/012169, Opinion Completed, Jul. 11, 2006.|
|U.S. Classification||141/10, 141/99, 141/114, 210/254, 141/105|
|Cooperative Classification||A61M5/1408, A61M5/16827, A61M39/00, A61J3/002|
|European Classification||A61J3/00B, A61M39/00|
|12 Oct 2009||AS||Assignment|
Owner name: B. BRAUN MEDICAL, INC.,PENNSYLVANIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BARTHOLOMEW, JOEL;REEL/FRAME:023358/0435
Effective date: 20040914
|8 Feb 2011||CC||Certificate of correction|
|23 May 2014||FPAY||Fee payment|
Year of fee payment: 4